MedTrace Logo

Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles

NCT02939898 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2019-02-05

No results posted yet for this study

Summary

The goal of this project is to identify autocrine, paracrine and endocrine factors which are associated with intercycle variation in cyclical follicle recruitment.

Patients will be monitored in a natural cycle, a stimulated cycle and a follow up. In the stimulated cycle patients will be randomized to co-treatment with aromatase inhibitor or placebo during ovarian stimulation.

Conditions

Interventions

DRUG

Placebo

Adjuvant therapy to recFSH during ovarian stimulation

DRUG

Letrozole

Adjuvant therapy to recFSH during ovarian stimulation

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Region Capital Denmark

    collaborator OTHER

  • Copenhagen University Hospital, Denmark

    collaborator OTHER

  • Sven O. Skouby

    lead OTHER

Principal Investigators

  • Sven O. Skouby, Professor · Unit of Reproductive Medicine, Herlev/Gentofte Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02939898 on ClinicalTrials.gov